128 related articles for article (PubMed ID: 29644923)
1. Patients' characteristics and their influence on course of fear during agoraphobic symptom provocation: may SS(N)RI treatment compensate unfavorable individual preconditions?
Plag J; Petzold MB; Gechter J; Liebscher C; Ströhle A
Nord J Psychiatry; 2018 Jul; 72(5):325-335. PubMed ID: 29644923
[TBL] [Abstract][Full Text] [Related]
2. Facing the fear--clinical and neural effects of cognitive behavioural and pharmacotherapy in panic disorder with agoraphobia.
Liebscher C; Wittmann A; Gechter J; Schlagenhauf F; Lueken U; Plag J; Straube B; Pfleiderer B; Fehm L; Gerlach AL; Kircher T; Fydrich T; Deckert J; Wittchen HU; Heinz A; Arolt V; Ströhle A
Eur Neuropsychopharmacol; 2016 Mar; 26(3):431-44. PubMed ID: 26837851
[TBL] [Abstract][Full Text] [Related]
3. The impact of depressive comorbidity on neural plasticity following cognitive-behavioral therapy in panic disorder with agoraphobia.
Kunas SL; Yang Y; Straube B; Kircher T; Gerlach AL; Pfleiderer B; Arolt V; Wittmann A; Stroehle A; Wittchen HU; Lueken U
J Affect Disord; 2019 Feb; 245():451-460. PubMed ID: 30428445
[TBL] [Abstract][Full Text] [Related]
4. Predictors of symptom resolution in panic disorder after one year of pharmacological treatment: a naturalistic study.
Marchesi C; Cantoni A; Fontò S; Giannelli MR; Maggini C
Pharmacopsychiatry; 2006 Mar; 39(2):60-5. PubMed ID: 16555166
[TBL] [Abstract][Full Text] [Related]
5. Personality traits in early phases of panic disorder: implications on the presence of agoraphobia, clinical severity and short-term outcome.
Carrera M; Herrán A; Ramírez ML; Ayestarán A; Sierra-Biddle D; Hoyuela F; Rodríguez-Cabo B; Vázquez-Barquero JL
Acta Psychiatr Scand; 2006 Dec; 114(6):417-25. PubMed ID: 17087790
[TBL] [Abstract][Full Text] [Related]
6. Fear of Fear and Broad Dimensions of Psychopathology over the Course of Cognitive Behavioural Therapy for Panic Disorder with Agoraphobia in Japan.
Ogawa S; Kondo M; Ino K; Ii T; Imai R; Furukawa TA; Akechi T
East Asian Arch Psychiatry; 2017 Dec; 27(4):150-5. PubMed ID: 29259145
[TBL] [Abstract][Full Text] [Related]
7. Selective serotonin reuptake inhibitors in the treatment of panic disorder and agoraphobia.
Bakker A; van Balkom AJ; van Dyck R
Int Clin Psychopharmacol; 2000 Aug; 15 Suppl 2():S25-30. PubMed ID: 11110016
[TBL] [Abstract][Full Text] [Related]
8. The relationship between agoraphobia symptoms and panic disorder in a non-clinical sample of adolescents.
Hayward C; Killen JD; Taylor CB
Psychol Med; 2003 May; 33(4):733-8. PubMed ID: 12785475
[TBL] [Abstract][Full Text] [Related]
9. Therapeutic response to phenelzine in patients with panic disorder and agoraphobia with panic attacks.
Buigues J; Vallejo J
J Clin Psychiatry; 1987 Feb; 48(2):55-9. PubMed ID: 3542985
[TBL] [Abstract][Full Text] [Related]
10. Provocation of panic: three elements of the panic reaction in four anxiety disorders.
Holt PE; Andrews G
Behav Res Ther; 1989; 27(3):253-61. PubMed ID: 2499302
[TBL] [Abstract][Full Text] [Related]
11. Cognitive-behavior therapy for discontinuation of SSRI treatment of panic disorder: a case series.
Whittal ML; Otto MW; Hong JJ
Behav Res Ther; 2001 Aug; 39(8):939-45. PubMed ID: 11480834
[TBL] [Abstract][Full Text] [Related]
12. Double-blind, fixed-dose, placebo-controlled study of paroxetine in the treatment of panic disorder.
Ballenger JC; Wheadon DE; Steiner M; Bushnell W; Gergel IP
Am J Psychiatry; 1998 Jan; 155(1):36-42. PubMed ID: 9433336
[TBL] [Abstract][Full Text] [Related]
13. Rate of improvement during and across three treatments for panic disorder with or without agoraphobia: cognitive behavioral therapy, selective serotonin reuptake inhibitor or both combined.
Van Apeldoorn FJ; Van Hout WJ; Timmerman ME; Mersch PP; den Boer JA
J Affect Disord; 2013 Sep; 150(2):313-9. PubMed ID: 23676529
[TBL] [Abstract][Full Text] [Related]
14. Antidepressants versus placebo for panic disorder in adults.
Bighelli I; Castellazzi M; Cipriani A; Girlanda F; Guaiana G; Koesters M; Turrini G; Furukawa TA; Barbui C
Cochrane Database Syst Rev; 2018 Apr; 4(4):CD010676. PubMed ID: 29620793
[TBL] [Abstract][Full Text] [Related]
15. A randomized, controlled trial of the effectiveness of cognitive-behavioral therapy and sertraline versus a waitlist control group for anxiety disorders in older adults.
Schuurmans J; Comijs H; Emmelkamp PM; Gundy CM; Weijnen I; van den Hout M; van Dyck R
Am J Geriatr Psychiatry; 2006 Mar; 14(3):255-63. PubMed ID: 16505130
[TBL] [Abstract][Full Text] [Related]
16. Panic attacks and agoraphobia: low dose clomipramine treatment.
Gloger S; Grunhaus L; Gladic D; O'Ryan F; Cohen L; Codner S
J Clin Psychopharmacol; 1989 Feb; 9(1):28-32. PubMed ID: 2651491
[TBL] [Abstract][Full Text] [Related]
17. The structure of phobias in panic disorder.
Argyle N; Solyom C; Solyom L
Br J Psychiatry; 1991 Sep; 159():378-82. PubMed ID: 1958949
[TBL] [Abstract][Full Text] [Related]
18. Trazodone in the treatment of panic disorder and agoraphobia with panic attacks.
Mavissakalian M; Perel J; Bowler K; Dealy R
Am J Psychiatry; 1987 Jun; 144(6):785-7. PubMed ID: 3296792
[TBL] [Abstract][Full Text] [Related]
19. Neural correlates of NOS1 ex1f-VNTR allelic variation in panic disorder and agoraphobia during fear conditioning and extinction in fMRI.
Ridderbusch IC; Yang Y; Weber H; Reif A; Herterich S; Ströhle A; Pfleiderer B; Arolt V; Wittchen HU; Lueken U; Kircher T; Straube B
Neuroimage Clin; 2020; 27():102268. PubMed ID: 32361414
[TBL] [Abstract][Full Text] [Related]
20. Heightened embarrassability discriminates between panic disorder patients with and without agoraphobia.
Swoboda H; Demal U; Krautgartner M; Amering M
J Behav Ther Exp Psychiatry; 2003; 34(3-4):195-204. PubMed ID: 14972667
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
